Key facts
- Yuzu’s last known valuation is $202.0M (Apr 2026).
- It has raised $40.5M across 2 recorded rounds; the latest was Early Stage VC ($35.0M) in Apr 2026.
- Notable investors include General Catalyst, Menlo Ventures, WndrCo, Lachy Groom, Day One Ventures — 18 tracked in total.
- Status: Privately Held (backing).
Leadership
- Max KaudererCo-Founder & CEO
- Russell PekalaCo-Founder
- Ryan LeeCo-Founder
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Yuzu
Funding rounds
2 roundsAbout Yuzu
Provider of health care plans intended to offer personalized plans for businesses. The company provides customizable healthcare plans that cover everything businesses and employees need for a reasonable rate, enabling businesses to get a health plan without the hassle of getting quotes and navigating confusing coverage.
- Industry
- Insurance
- Sector
- Financial Services
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 63
- Website
- yuzu.health/
- Ownership
- Privately Held (backing)
Yuzu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuzu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuzu in its N-PORT filings yet. We sweep new filings monthly.